Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1947 2
1948 1
1949 1
1951 2
1952 4
1953 5
1954 3
1955 3
1956 4
1957 2
1958 10
1959 3
1960 5
1961 6
1962 2
1963 4
1964 10
1965 6
1966 6
1967 10
1968 5
1969 4
1970 8
1971 5
1972 6
1973 9
1974 9
1975 10
1976 13
1977 12
1978 13
1979 23
1980 18
1981 14
1982 10
1983 14
1984 10
1985 18
1986 15
1987 14
1988 17
1989 20
1990 24
1991 29
1992 20
1993 15
1994 19
1995 22
1996 19
1997 15
1998 17
1999 28
2000 29
2001 25
2002 26
2003 19
2004 24
2005 24
2006 12
2007 21
2008 30
2009 33
2010 39
2011 39
2012 36
2013 37
2014 41
2015 44
2016 52
2017 58
2018 48
2019 35
2020 48
2021 49
2022 42
2023 43
2024 17

Text availability

Article attribute

Article type

Publication date

Search Results

1,333 results

Results by year

Filters applied: . Clear all
Page 1
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Among authors: holt s. Lancet. 2019 Jul 13;394(10193):121-130. doi: 10.1016/S0140-6736(19)31149-3. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189511 Clinical Trial.
Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
Haddad RI, Bischoff L, Ball D, Bernet V, Blomain E, Busaidy NL, Campbell M, Dickson P, Duh QY, Ehya H, Goldner WS, Guo T, Haymart M, Holt S, Hunt JP, Iagaru A, Kandeel F, Lamonica DM, Mandel S, Markovina S, McIver B, Raeburn CD, Rezaee R, Ridge JA, Roth MY, Scheri RP, Shah JP, Sipos JA, Sippel R, Sturgeon C, Wang TN, Wirth LJ, Wong RJ, Yeh M, Cassara CJ, Darlow S. Haddad RI, et al. Among authors: holt s. J Natl Compr Canc Netw. 2022 Aug;20(8):925-951. doi: 10.6004/jnccn.2022.0040. J Natl Compr Canc Netw. 2022. PMID: 35948029
AUTHOR REPLY.
Peters CE, Lee J, Holt SK, Wolff E, Gore JL, Seideman CA. Peters CE, et al. Among authors: holt sk. Urology. 2023 Oct;180:301-302. doi: 10.1016/j.urology.2023.04.046. Epub 2023 Aug 8. Urology. 2023. PMID: 37558582 No abstract available.
Multicenter Evaluation of BioFire FilmArray Meningitis/Encephalitis Panel for Detection of Bacteria, Viruses, and Yeast in Cerebrospinal Fluid Specimens.
Leber AL, Everhart K, Balada-Llasat JM, Cullison J, Daly J, Holt S, Lephart P, Salimnia H, Schreckenberger PC, DesJarlais S, Reed SL, Chapin KC, LeBlanc L, Johnson JK, Soliven NL, Carroll KC, Miller JA, Dien Bard J, Mestas J, Bankowski M, Enomoto T, Hemmert AC, Bourzac KM. Leber AL, et al. Among authors: holt s. J Clin Microbiol. 2016 Sep;54(9):2251-61. doi: 10.1128/JCM.00730-16. Epub 2016 Jun 22. J Clin Microbiol. 2016. PMID: 27335149 Free PMC article.
SARM1 is a metabolic sensor activated by an increased NMN/NAD+ ratio to trigger axon degeneration.
Figley MD, Gu W, Nanson JD, Shi Y, Sasaki Y, Cunnea K, Malde AK, Jia X, Luo Z, Saikot FK, Mosaiab T, Masic V, Holt S, Hartley-Tassell L, McGuinness HY, Manik MK, Bosanac T, Landsberg MJ, Kerry PS, Mobli M, Hughes RO, Milbrandt J, Kobe B, DiAntonio A, Ve T. Figley MD, et al. Among authors: holt s. Neuron. 2021 Apr 7;109(7):1118-1136.e11. doi: 10.1016/j.neuron.2021.02.009. Epub 2021 Mar 2. Neuron. 2021. PMID: 33657413 Free PMC article.
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Botros FT, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Among authors: holt s. Lancet. 2019 Jul 13;394(10193):131-138. doi: 10.1016/S0140-6736(19)31150-X. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189509 Clinical Trial.
Overcoming breastfeeding challenges.
Syme J, Holt S, Fell K, Crawley L. Syme J, et al. Among authors: holt s. Community Pract. 2015 Jun;88(6):29-31; quiz 31. Community Pract. 2015. PMID: 26373003 Review. No abstract available.
AUTHOR REPLY.
Whitley JA, Holt SK, Nelson D, Kieran K. Whitley JA, et al. Among authors: holt sk. Urology. 2021 Apr;150:15. doi: 10.1016/j.urology.2020.07.082. Urology. 2021. PMID: 33812539 No abstract available.
Pharmacotherapy for Alcohol Use Disorder.
Holt SR, Tobin DG. Holt SR, et al. Med Clin North Am. 2018 Jul;102(4):653-666. doi: 10.1016/j.mcna.2018.02.008. Epub 2018 Apr 26. Med Clin North Am. 2018. PMID: 29933821 Review.
1,333 results